Patient-Reported Outcome Consortium
The Patient-Reported Outcome Consortium supports patient-focused drug development by obtaining qualification of clinical outcome assessment tools that measure how patients feel and function in their everyday lives as a result of treatment.
News
-
Jan 7, 2021 Diary for Irritable Bowel Syndrome Symptoms-Constipation is the First Patient-Reported Outcome Consortium Measure Used to Support an FDA-approved Label Claim
-
Sep 21, 2020 C-Path Awarded FDA Drug Development Tool Research Grant to Develop a Qualification Plan for the Symptoms of Major Depressive Disorder Momentary Assessment (SMDDMA)
Past Events
-
Feb 17, 2021 WEBINAR: eCOA: Getting Better Together Initiative – An Update from C-Path’s PRO Consortium and ePRO Consortium -
Apr 22, 2020 - Apr 23, 2020 11th Annual Patient-Reported Outcome Consortium Workshop – Cancelled
Publications
-
Sep 13, 2019 Symptoms of Major Depressive Disorder Scale: Performance of a Novel Patient-Reported Symptom Measure -
Sep 6, 2018 Response scale selection in adult pain measures: results from a literature review
-
Sep 6, 2018 Literature review to characterize the empirical basis for response scale selection in pediatric populations
-
Sep 6, 2018 Literature review to assemble the evidence for response scales used in patient-reported outcome measures
-
Jun 1, 2018 Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop